Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Quality Index
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Quality Index of -5.35x as of June 2023. Operating cash flow of CN¥-455.48 Million is below net income of CN¥85.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Zhejiang Orient Gene Biotech Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Quality Index (2016–2022)
Historical Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Orient Gene Biotech Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year earnings quality comparison for Zhejiang Orient Gene Biotech Co Ltd. For live market cap and the full company financial profile, see market value of Zhejiang Orient Gene Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.43x | CN¥3.00 Billion | CN¥2.10 Billion | ▲ +35.6% |
| 2021 | 1.05x | CN¥5.20 Billion | CN¥4.94 Billion | ▼ -1.1% |
| 2020 | 1.07x | CN¥1.79 Billion | CN¥1.68 Billion | ▲ +52.3% |
| 2019 | 0.70x | CN¥54.21 Million | CN¥77.51 Million | ▲ +0.9% |
| 2018 | 0.69x | CN¥44.33 Million | CN¥63.96 Million | ▼ -32.4% |
| 2017 | 1.03x | CN¥33.54 Million | CN¥32.71 Million | ▲ +209.4% |
| 2016 | 0.33x | CN¥11.81 Million | CN¥35.63 Million | — |